RhoA S‐nitrosylation as a regulatory mechanism influencing endothelial barrier function in response to G+‐bacterial toxins

[1]  Hua Yang,et al.  Aryl Hydrocarbon Receptor Activation in Intestinal Obstruction Ameliorates Intestinal Barrier Dysfunction Via Suppression of MLCK-MLC Phosphorylation Pathway , 2016, Shock.

[2]  F. Gao,et al.  Akt1 promotes stimuli-induced endothelial-barrier protection through FoxO-mediated tight-junction protein turnover , 2016, Cellular and Molecular Life Sciences.

[3]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[4]  A. Orekhov,et al.  Endothelial Barrier and Its Abnormalities in Cardiovascular Disease , 2015, Front. Physiol..

[5]  F. Chen,et al.  Nox5 stability and superoxide production is regulated by C-terminal binding of Hsp90 and CO-chaperones. , 2015, Free Radical Biology & Medicine.

[6]  F. Chen,et al.  Enzymatic regulation and functional relevance of NOX5. , 2015, Current pharmaceutical design.

[7]  T. Beißbarth,et al.  Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study , 2015, BMC Medicine.

[8]  Yunchao Su,et al.  Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species. , 2014, Free radical biology & medicine.

[9]  Yunchao Su,et al.  NADPH Oxidase 4 Is Expressed in Pulmonary Artery Adventitia and Contributes to Hypertensive Vascular Remodeling , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[10]  J. Catravas,et al.  PKC-Dependent Phosphorylation of eNOS at T495 Regulates eNOS Coupling and Endothelial Barrier Function in Response to G+ -Toxins , 2014, PloS one.

[11]  Atsushi Tanaka,et al.  Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma , 2014, Nature Genetics.

[12]  J. Catravas,et al.  Lipopolysaccharide-induced Lung Injury Involves the Nitration-mediated Activation of RhoA* , 2014, The Journal of Biological Chemistry.

[13]  J. Catravas,et al.  Heat shock protein 90 inhibitors prevent LPS-induced endothelial barrier dysfunction by disrupting RhoA signaling. , 2013, American journal of respiratory cell and molecular biology.

[14]  Jennifer L Greene,et al.  Mass spectrometry-based identification of S-nitrosocysteine in vivo using organic mercury assisted enrichment. , 2013, Methods.

[15]  J. Catravas,et al.  Opposing Actions of Heat Shock Protein 90 and 70 Regulate Nicotinamide Adenine Dinucleotide Phosphate Oxidase Stability and Reactive Oxygen Species Production , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J. Catravas,et al.  Protein kinase C-α and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability. , 2012, American journal of respiratory cell and molecular biology.

[17]  S. Barman,et al.  From form to function: the role of Nox4 in the cardiovascular system , 2012, Front. Physio..

[18]  M. A. Moseley,et al.  Nitric oxide reduces NADPH oxidase 5 (Nox5) activity by reversible S-nitrosylation. , 2012, Free radical biology & medicine.

[19]  A. Bresnick,et al.  The suppression of myosin light chain (MLC) phosphorylation during the response to lipopolysaccharide (LPS): beneficial or detrimental to endothelial barrier? , 2011, Journal of cellular physiology.

[20]  R. D. Rudic,et al.  Tissue-intrinsic dysfunction of circadian clock confers transplant arteriosclerosis , 2011, Proceedings of the National Academy of Sciences.

[21]  A. Malik,et al.  Caveolin-1–eNOS signaling promotes p190RhoGAP-A nitration and endothelial permeability , 2011, The Journal of cell biology.

[22]  J. Stamler,et al.  Identification of S-nitrosylated targets of thioredoxin using a quantitative proteomic approach. , 2010, Biochemistry.

[23]  J. Gratton,et al.  S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability. , 2010, Molecular cell.

[24]  W. Durán,et al.  The NO cascade, eNOS location, and microvascular permeability. , 2010, Cardiovascular research.

[25]  L. Jackson,et al.  Clinical and economic burden of pneumococcal disease in older US adults. , 2010, Vaccine.

[26]  E. Lemichez,et al.  Direct modifications of Rho proteins: deconstructing GTPase regulation , 2010, Biology of the cell.

[27]  J. Catravas,et al.  The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells - a crucial role for protein kinase C-alpha inhibition. , 2010, Vascular pharmacology.

[28]  D. Fulton,et al.  An Inhibitor of Protein Arginine Methyltransferases, 7,7′-Carbonylbis(azanediyl)bis(4-hydroxynaphthalene-2-sulfonic acid (AMI-1), Is a Potent Scavenger of NADPH-Oxidase–Derived Superoxide , 2010, Molecular Pharmacology.

[29]  Matthew W. Foster,et al.  A protein microarray-based analysis of S-nitrosylation , 2009, Proceedings of the National Academy of Sciences.

[30]  J. Stamler,et al.  Protein denitrosylation: enzymatic mechanisms and cellular functions , 2009, Nature Reviews Molecular Cell Biology.

[31]  J. Stamler,et al.  Detection of protein S-nitrosylation with the biotin-switch technique. , 2009, Free radical biology & medicine.

[32]  K. Birukov.  Small GTPases in mechanosensitive regulation of endothelial barrier. , 2009, Microvascular research.

[33]  J. Hare,et al.  Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes , 2007, Proceedings of the National Academy of Sciences.

[34]  F. Wouters,et al.  Cholesterol-dependent actin remodeling via RhoA and Rac1 activation by the Streptococcus pneumoniae toxin pneumolysin , 2007, Proceedings of the National Academy of Sciences.

[35]  B. Zuckerbraun,et al.  Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA. , 2007, American journal of physiology. Cell physiology.

[36]  M. Chvanov,et al.  Calcium‐dependent release of NO from intracellular S‐nitrosothiols , 2006, The EMBO journal.

[37]  J. R. de los Toyos,et al.  Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia , 2006, Critical care medicine.

[38]  A. O’Brien,et al.  A single amino acid substitution in the enzymatic domain of cytotoxic necrotizing factor type 1 of Escherichia coli alters the tissue culture phenotype to that of the dermonecrotic toxin of Bordetella spp. , 2006, Molecular microbiology.

[39]  R. Wysolmerski,et al.  Myosin Phosphatase and Cofilin Mediate cAMP/cAMP-dependent Protein Kinase-induced Decline in Endothelial Cell Isometric Tension and Myosin II Regulatory Light Chain Phosphorylation* , 2005, Journal of Biological Chemistry.

[40]  D. Predescu,et al.  Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[41]  M. Marletta,et al.  Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine , 2005, Nature chemical biology.

[42]  A. Lin,et al.  Receptor-regulated Dynamic S-Nitrosylation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells* , 2005, Journal of Biological Chemistry.

[43]  S. Rounds,et al.  Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[44]  E. Block,et al.  Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells , 2003, Molecular and Cellular Biochemistry.

[45]  M. Yamakuchi,et al.  Nitric Oxide Regulates Exocytosis by S-Nitrosylation of N-ethylmaleimide-Sensitive Factor , 2003, Cell.

[46]  AndreasFriebe,et al.  Regulation of Nitric Oxide-Sensitive Guanylyl Cyclase , 2003 .

[47]  Santiago Lamas,et al.  Nitrosylation The Prototypic Redox-Based Signaling Mechanism , 2001, Cell.

[48]  A. Hausladen,et al.  Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. , 2001, Biochemistry.

[49]  M. Zeng,et al.  A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans , 2001, Nature.

[50]  U. Rapp,et al.  Deamidation of Cdc42 and Rac by Escherichia coliCytotoxic Necrotizing Factor 1: Activation of c-Jun N-Terminal Kinase in HeLa Cells , 1999, Infection and Immunity.

[51]  K. Aktories,et al.  Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling. , 1998, Biochemistry.

[52]  J. Stamler,et al.  Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. , 1998, Science.

[53]  Salvador Moncada,et al.  NITRIC OXIDE PHYSIOLOGY , 1997 .

[54]  J. Stamler,et al.  S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control , 1996, Nature.

[55]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.